![Kenneth J. Dow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth J. Dow
Compliance Officer bei CENTURY THERAPEUTICS, INC.
Aktive Positionen von Kenneth J. Dow
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CENTURY THERAPEUTICS, INC. | Compliance Officer | - | - |
General Counsel | - | - |
Karriereverlauf von Kenneth J. Dow
Ehemalige bekannte Positionen von Kenneth J. Dow
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Janssen Biotech, Inc.
![]() Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Corporate Officer/Principal | - | - |
Johnson & Johnson Law Department Europe
![]() Johnson & Johnson Law Department Europe Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Johnson & Johnson Law Department Europe provides legal services. The company is based in Buckinghamshire, UK. | Corporate Officer/Principal | - | - |
Century Therapeutics, Inc. /Old/
![]() Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Century Therapeutics, Inc. operates as a biotechnology company. It develops transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need. The company has created a allogeneic cell therapy platform that includes induced pluripotent stem cells, or iPSCs, differentiation know-how to generate immune effector cells from iPSCs, or iPSC-derived cells, clustered regularly interspaced short palindromic repeats, or CRISPR, mediated precision gene editing that allows it to incorporate multiple transgenes and remove target genes intended to optimize cell product performance, sophisticated protein engineering capabilities to develop proprietary next generation chimeric antigen receptors, or CARs, its proprietary Allo-EvasionTM technology intended to prevent rejection of its cell products by the host immune system, and cutting edge manufacturing capabilities intended to minimize product development and supply risk. Century Therapeutics was founded on March 5th, 2018 and is headquartered by Philadelphia, PA. | General Counsel | - | - |
Ausbildung von Kenneth J. Dow
State University of New York at Buffalo | Undergraduate Degree |
St. John's University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 2 |
Operativ
General Counsel | 2 |
Corporate Officer/Principal | 2 |
Compliance Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CENTURY THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Century Therapeutics, Inc. /Old/
![]() Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Century Therapeutics, Inc. operates as a biotechnology company. It develops transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need. The company has created a allogeneic cell therapy platform that includes induced pluripotent stem cells, or iPSCs, differentiation know-how to generate immune effector cells from iPSCs, or iPSC-derived cells, clustered regularly interspaced short palindromic repeats, or CRISPR, mediated precision gene editing that allows it to incorporate multiple transgenes and remove target genes intended to optimize cell product performance, sophisticated protein engineering capabilities to develop proprietary next generation chimeric antigen receptors, or CARs, its proprietary Allo-EvasionTM technology intended to prevent rejection of its cell products by the host immune system, and cutting edge manufacturing capabilities intended to minimize product development and supply risk. Century Therapeutics was founded on March 5th, 2018 and is headquartered by Philadelphia, PA. | Health Technology |
Janssen Biotech, Inc.
![]() Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Health Technology |
Johnson & Johnson Law Department Europe
![]() Johnson & Johnson Law Department Europe Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Johnson & Johnson Law Department Europe provides legal services. The company is based in Buckinghamshire, UK. | Commercial Services |
- Börse
- Insiders
- Kenneth J. Dow
- Erfahrung